Cargando…
CD161 Characterizes an Inflamed Subset of Cytotoxic T Lymphocytes Associated with Prolonged Survival in Human Papillomavirus–Driven Oropharyngeal Cancer
Human papillomavirus (HPV)–driven oropharyngeal carcinoma (OPSCC) is distinct from tobacco- or alcohol-associated OPSCC and has a unique immune landscape. Studies have supported the heterogeneity of T cells, accompanied by a broad repertoire of T-cell responses, within tumors driven by HPV infection...
Autores principales: | Wei, Ye, Xu, Tingting, Li, Chong, Zhou, Xin, Qian, Wei, Shen, Chunying, Wang, Qifeng, Xing, Xing, Ou, Xiaomin, He, Xiayun, Yin, Hongmei, Hu, Chaosu, Wang, Yu, Ji, Qinghai, Su, Fengtao, Lu, Xueguan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975669/ https://www.ncbi.nlm.nih.gov/pubmed/36633583 http://dx.doi.org/10.1158/2326-6066.CIR-22-0454 |
Ejemplares similares
-
Human papillomavirus (HPV) in Chinese oropharyngeal squamous cell carcinoma (OPSCC): A strong predilection for the tonsil
por: Xu, Tingting, et al.
Publicado: (2020) -
Response to induction chemotherapy predicts survival outcomes in oropharyngeal cancer
por: Zhang, Qixian, et al.
Publicado: (2023) -
The role of adjuvant chemotherapy in nasopharyngeal carcinoma with bulky neck lymph nodes in the era of IMRT
por: Xu, Tingting, et al.
Publicado: (2016) -
Who benefited most from higher cumulative dose of cisplatin among patients with locally advanced nasopharyngeal carcinoma treated by intensity-modulated radiation therapy? A retrospective study of 527 cases
por: Ou, Xiaomin, et al.
Publicado: (2017) -
Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost
por: Ou, Xiaomin, et al.
Publicado: (2015)